m-AMSA and PALA: Two new agents in cancer chemotherapy M. RozencweigD. D. Von HoffF. M. Muggia General Review Pages: 135 - 141
Pharmacokinetic monitoring of high-dose methotrexate William E. EvansCharles B. PrattWilliam R. Crom Original Articles Pages: 161 - 166
Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostatic adenocarcinoma Joseph R. DragoRobert E. MaurerM. Eric Gershwin Original Articles Pages: 167 - 170
Disposition and metabolism of bruceantin in the mouse William J. SulingCarolyn W. WoolleyWilliam M. Shannon Original Articles Pages: 171 - 176
Evaluation of 24-hour infusion of high-dose methotrexate —Pharmacokinetics and toxicity T. S. GohK. Y. WongDavid Gnarra Original Articles Pages: 177 - 180
Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides G. PeterH.-J. Hohorst Original Articles Pages: 181 - 188
High-dose methotrexate: Preliminary evaluation of a pharmacokinetic approach S. MonjanelJ. P. RigaultR. Favre Original Articles Pages: 189 - 196
Sequential chemotherapy and circadian rhythm in human solid tumours C. Focan Original Articles Pages: 197 - 202